IMDYLLTRA 1 mg powder for concentrate and solution for solution for infusion
*Company:
Amgen Ireland LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
File name
IMDYLLTRA (tarlatamab) IE aRMM Patient Alert Card v1.pdf
Reasons for updating
- Add New Doc
Free text change information supplied by the pharmaceutical company
New Patient Card
File name
IMDYLLTRA (tarlatamab) IE aRMM Patient Alert Card v1.pdf
Reasons for updating
- Add New Doc
Free text change information supplied by the pharmaceutical company
New Patient Card
Updated on 07 July 2026
File name
ie_Imdylltra_approved_spc_MAA.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 07 July 2026
File name
ie_Imdylltra_approved_pil_MAA.pdf
Reasons for updating
- New PIL for new product
Amgen Ireland Ltd
Address:
21 Northwood Court, Santry, Dublin D09 TX31, Ireland, 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UKMedical Information E-mail:
gbinfoline@amgen.comTelephone:
+44 (0)1223 420 305Website:
https://www.amgen.co.ukMedical Information Direct Line:
+44 (0)1223 436 441/Freephone: 1800 535160Customer Care direct line:
+44 (0)1223 436441/Freephone: 1800 535160